1. Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
    Salvatore Sciacchitano et al, 2018, IJMS CrossRef
  2. Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications
    Nicolas Clementy et al, 2018, IJMS CrossRef
  3. Subclinical myocardial injury during vaso-occlusive crisis in pediatric sickle cell disease
    Reham Wagdy et al, 2018, Eur J Pediatr CrossRef
  4. Circulating Galectin-3 and Atrial Fibrillation Recurrence after Catheter Ablation: A Meta-Analysis
    Guangping Zhang et al, 2019, Cardiovascular Therapeutics CrossRef
  5. Elevated Platelet Galectin-3 and Rho-Associated Protein Kinase Activity Are Associated with Hemodialysis Arteriovenous Shunt Dysfunction among Subjects with Diabetes Mellitus
    Po-Wei Chen et al, 2019, BioMed Research International CrossRef
  6. The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in Children
    Felipe Leite de Oliveira et al, 2019, IJMS CrossRef
  7. Pleiotropic Effects of Modified Citrus Pectin
    Isaac Eliaz et al, 2019, Nutrients CrossRef
  8. Calreticulin and Galectin-3 Opsonise Bacteria for Phagocytosis by Microglia
    Tom O. J. Cockram et al, 2019, Front. Immunol. CrossRef
  9. Role of oxidative stress-related biomarkers in heart failure: galectin 3, α1-antitrypsin and LOX-1: new therapeutic perspective?
    Valter Lubrano et al, 2019, Mol Cell Biochem CrossRef
  10. FOXD1 and Gal-3 Form a Positive Regulatory Loop to Regulate Lung Cancer Aggressiveness
    Chien-Hsiu Li et al, 2019, Cancers CrossRef
  11. Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases
    Akira Hara et al, 2020, Biomolecules CrossRef
  12. Non-classical role of Galectin-3 in cancer progression: translocation to nucleus by carbohydrate-recognition independent manner
    Seok-Jun Kim et al, 2020, BMB Rep. CrossRef
  13. Glycosylation and raft endocytosis in cancer
    Ludger Johannes et al, 2020, Cancer Metastasis Rev CrossRef
  14. Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?
    Yoshio Sumida et al, 2020, IJMS CrossRef
  15. Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling
    Moustafa Gabr et al, 2020, ACS Med. Chem. Lett. CrossRef
  16. Evaluation of serum galectin-3 levels at Alzheimer patients by stages: a preliminary report
    Tamer Yazar et al, 2020, Acta Neurol Belg CrossRef
  17. Galectin-3 as a Therapeutic Target for NSAID-Induced Intestinal Ulcers
    Ah-Mee Park et al, 2020, Front. Immunol. CrossRef
  18. Galectin-3: A Potential Prognostic and Diagnostic Marker for Heart Disease and Detection of Early Stage Pathology
    Akira Hara et al, 2020, Biomolecules CrossRef
  19. Valid cardiac biochemical markers. Part II
    N. G. Gumanova et al, 2020, Cardiovasc Ther Prev CrossRef
  20. Galectin-3 in Cardiovascular Diseases
    Valeria Blanda et al, 2020, IJMS CrossRef
  21. The Extracellular Matrix-Derived Biomarkers for Diagnosis, Prognosis, and Personalized Therapy of Malignant Tumors
    Elena V. Petersen et al, 2020, Front. Oncol. CrossRef
  22. Implications of Glycosylation in Alzheimer’s Disease
    Henriette Haukedal et al, 2021, Front. Neurosci. CrossRef
  23. Inhibition of ATGL in adipose tissue ameliorates isoproterenol-induced cardiac remodeling by reducing adipose tissue inflammation
    Shingo Takahara et al, 2021, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
  24. Galectin-3 mediates cardiac remodeling caused by impaired glucose and lipid metabolism through inhibiting two pathways of activating Akt
    Zhen Sun et al, 2021, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
  25. Glycans and Glycan-Binding Proteins as Regulators and Potential Targets in Leukocyte Recruitment
    Franziska Krautter et al, 2021, Front. Cell Dev. Biol. CrossRef
  26. New biomarkers of injury, inflammation and remodeling in the differential diagnosis of heart failure types
    E. K. Serezhina et al, 2021, Russ J Cardiol CrossRef
  27. Reprogramming the tumor metastasis cascade by targeting galectin-driven networks
    Ramiro M. Perrotta et al, 2021 CrossRef
  28. Review of Galectin-3 inhibitors in the treatment of nonalcoholic steatohepatitis
    Atef Al Attar et al, 2021, Expert Review of Clinical Pharmacology CrossRef
  29. Activation of AMPK inhibits Galectin-3-induced pulmonary artery smooth muscle cells proliferation by upregulating hippo signaling effector YAP
    Qianqian Zhang et al, 2021, Mol Cell Biochem CrossRef
  30. Disorders of carbohydrate-lipid metabolism and galectin-3 level as factors of liver fibrosis progression in chronic hepatitis C
    V. A. Kovalevа et al, 2021, Terapevticheskii arkhiv CrossRef
  31. Galectin-3 Mediated Inflammatory Response Contributes to Neurological Recovery by QiShenYiQi in Subacute Stroke Model
    Yule Wang et al, 2021, Front. Pharmacol. CrossRef
  32. Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?
    Masataka Yokode et al, 2021, Diagnostics CrossRef
  33. Galectin-3—A New Player of Kidney Damage or an Innocent Bystander in Children with a Single Kidney?
    Eryk Latoch et al, 2021, JCM CrossRef
  34. Heart Failure and Diabetes Mellitus: Biomarkers in Risk Stratification and Prognostication
    Michael Lichtenauer et al, 2021, Applied Sciences CrossRef
  35. The Antiviral Role of Galectins toward Influenza A Virus Infection—An Alternative Strategy for Influenza Therapy
    Chih-Yen Lin et al, 2021, Pharmaceuticals CrossRef
  36. The Therapeutic Potential of Galectin-3 in the Treatment of Intrahepatic Cholangiocarcinoma Patients and Those Compromised With COVID-19
    Hao Li et al, 2021, Front. Mol. Biosci. CrossRef
  37. Correlation between Biomarkers and Ischemic Stroke
    明敏 梁, 2021, ACM CrossRef
  38. Mesenchymal stem cells ameliorate renal fibrosis by galectin-3/Akt/GSK3β/Snail signaling pathway in adenine-induced nephropathy rat
    Huajun Tang et al, 2021, Stem Cell Res Ther CrossRef
  39. Analysis of the Correlation of Galectin-3 Concentration with the Measurements of Echocardiographic Parameters Assessing Left Atrial Remodeling and Function in Patients with Persistent Atrial Fibrillation
    Paweł Wałek et al, 2021, Biomolecules CrossRef
  40. Anti-Cancer Potential of Afzelin towards AGS Gastric Cancer Cells
    Iwona Radziejewska et al, 2021, Pharmaceuticals CrossRef
  41. Physical Activity Attenuates the Obesity-Induced Dysregulated Expression of Brown Adipokines in Murine Interscapular Brown Adipose Tissue
    Takuya Sakurai et al, 2021, IJMS CrossRef
  42. Circulating Galectin-3 Evaluation in Dogs With Cardiac and Non-cardiac Diseases
    Ga-Won Lee et al, 2021, Front. Vet. Sci. CrossRef
  43. Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy
    Luca Muzio et al, 2021, Front. Neurosci. CrossRef
  44. Combination Informatic and Experimental Approach for Selecting Scaffold Proteins for Development as Antibody Mimetics
    Tomoyuki Ito et al, 2021, Chem. Lett. CrossRef
  45. Biomarkers Utility: At the Borderline between Cardiology and Neurology
    Adriana Ion et al, 2021, JCDD CrossRef
  46. Emerging role of signal transducer and activator of transcription 3 (STAT3) in pituitary adenomas
    Cyndy Liu et al, 2021, Endocr J CrossRef
  47. RNA-seq driven expression and enrichment analysis to investigate CVD genes with associated phenotypes among high-risk heart failure patients
    Zeeshan Ahmed et al, 2021, Hum Genomics CrossRef
  48. “Multiomics” Approaches to Understand and Treat COVID-19: Mass Spectrometry and Next-Generation Sequencing
    Diane Appiasie et al, 2021, BioChem CrossRef